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KEY MESSAGES
 Heart failure diagnosis is not always properly classified in primary care medical records.
 Variables regularly registered in the clinical records of patients with heart failure could help general practi-
tioners who suspect that the diagnosis has to be revised.
ABSTRACT
Background: Heart failure (HF) diagnosis as reported in primary care medical records is not
always properly confirmed and could result in over-registration.
Objectives: To determine the proportion of registered HF that can be confirmed with informa-
tion from primary care medical records and to analyse related factors.
Methods: A cross-sectional study. The medical records of 595 HF patients attended in two pri-
mary healthcare centres in Barcelona (Spain) were revised and validated by a team of experts
who classified diagnosis into confirmed, unconfirmed, and misdiagnosis. Variables potentially
related to the confirmation of the diagnosis were analysed. The revision of medical records and
data collection took place from 15 January to 31 March 2014.
Results: Mean (standard deviation) age was 78 (10) years and 58% were women. The diagnosis
could be confirmed in 53.6% of patients. Factors associated with a greater probability of having a
confirmed diagnosis were age (yearly OR: 0.97, 95%CI: 0.95–0.99), cardiologist follow-up (OR: 3.66,
95%CI: 2.46–5.48), history of ischaemic heart disease (OR: 2.18, 95%CI: 1.36–2.48), atrial fibrillation
(OR: 2.01, 95%CI: 1.34–3.03), and prescription of loop diuretics (OR: 3.24, 95%CI: 2.14–4.89).
Conclusion: Only in half of the patients labelled as HF in primary care medical records could
this diagnosis be further confirmed. Variables regularly registered in clinical practice could help
general practitioners identify those patients requiring a revision of their HF diagnosis.
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Introduction
Heart failure (HF) is a major public health concern. Its
incidence increases with age from 1% in individuals
aged less than 50 years to 8% in those over 75 [1].
Recent population-based studies conducted in Spain
have shown a prevalence of 4% to 7%, which can
reach up to 16% in elderly patients [2,3].
The role of general practitioners (GPs) in the initial
diagnosis and management of patients with HF has
been well documented, particularly in elderly populations
with comorbidity and polypharmacy [3–6]. Diagnosis
requires demonstrating cardiac dysfunction and remains a
challenge: HF signs and symptoms are not specific and
in many cases difficult to identify [1,3,5,7–11].
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It comprises a wide range of patients from those with
HF with preserved ejection fraction (HF-PEF) to those
with reduced ejection fraction (HF-REF) with
LEVF<40%. Differentiation of patients with HF based on
LVEF is important due to distinct underlying aetiologies,
demographics, comorbidities, and therapy response [1].
Even thoughHF diagnosis requires demonstrating car-
diac dysfunction, it has been reported that 20% to 40% of
HF patients had not had an echocardiogram registered in
their primary care medical records [4,6,12]. Based on
these data, in previous studies [11,13–17], HF diagnosis
had been confirmed in 35% to 85% of the registered
cases. To date, evidence regarding the factors associated
with a confirmed diagnosis of HF is scarce [18–20].
It has also been recently argued that a well-docu-
mented previous hospital admission because of HF
could be considered as proof of properly identified
diagnosis [2,3,5,21].
The aim of this study was to determine the propor-
tion of registered HF, which can be confirmed with
information from primary care medical records and to
analyse the related factors.
Methods
Study design
A cross-sectional study was carried out in two primary
care centres (PCC) located in Barcelona, which provide
healthcare to 39 000 individuals. The medical records
of all patients registered with an HF diagnosis were
reviewed. Since both PCCs belong to the Catalan
Health Institute, they use the same electronic medical
record system. In computerized medical records, infor-
mation on symptoms, examination, comorbidities,
complementary tests, and patient referrals is systemat-
ically collected.
An integrated healthcare programme in which car-
diologists provide support to GPs by sharing consulta-
tions and training programmes is also included in this
system [22].
Ethics
This study complies with the Declaration of Helsinki.
Ethical approval was obtained from the Health Care
Ethics Committee of the Institut d'Investigacio en
Atencio Primaria Jordi Gol (reference number P14/021).
Study population and inclusion criteria
Inclusion criteria. All patients aged >14 years regis-
tered on 1 January 2014 with the diagnostic code I.50
(I.50.0: congestive HF, I.50.1: left ventricular HF) accord-
ing to the International Classification of Diseases (tenth
revision) were included.
Exclusion criteria. Deceased patients and those who
had moved to other PCCs were excluded, since
updated information was not available.
Study period. The revision of clinical records and data
collection took place from 15 January to 31 March
2014.
Confirmatory diagnosis of HF
A reference panel consisting of a specifically trained
GP and a cardiologist classified patients into con-
firmed, unconfirmed, and misdiagnosis, according to
the following criteria:
1. Confirmed HF (at least one of the following):
1.1. Presence in the primary care medical records of
typical HF signs and symptoms (dyspnoea, orthop-
noea, paroxysmal nocturnal dyspnoea, oedema,
elevated jugular venous pressure, third heart
sound) along with an echocardiography showing
structural anomalies of HF according to the
European Society of Cardiology [1,9].
1.2. The existence of an echocardiography showing
structural anomalies of HF in the primary care
electronic medical records without typical HF
signs and symptoms (asymptomatic HF) [1,9].
1.3. Information about a hospitalization because of
HF [23].
2. Misdiagnosis of HF was considered if:
2.1 Typical HF signs and symptoms are registration in
the primary care medical records but echocardiog-
raphy did not show structural abnormalities.
2.2. Neither registration of typical HF signs and symp-
toms nor echocardiography showed structural
abnormalities.
3. Unconfirmed diagnosis was considered if echocar-
diography had not been performed or information
about the procedure was unavailable.
Variables
The research team reviewed the medical records of
the patients included. To confirm the primary outcome
(confirmatory diagnosis of HF), they collected the vari-
ables needed to establish the diagnosis of HF: typical
HF signs and symptoms, left echocardiographic find-
ings (ventricular ejection fraction, abnormalities of
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diastolic relaxation, or left atrial enlargement, or left
ventricular hypertrophy, and or moderate or severe
valve disease), and the previous hospitalization as a
consequence of HF was also taken into account.
To analyse the variables related with confirmed HF,
data related to the diagnosis of HF in the literature
were collected in addition to information from the
electronic medical record system (Table 1) such as
loop diuretic prescription, demographic characteristics,
date of HF diagnosis, and whether patients were see-
ing a cardiologist [1,19,20]. The following comorbid-
ities were analysed: hypercholesterolaemia,
hypertension, diabetes mellitus, ischaemic heart dis-
ease, chronic obstructive pulmonary disease, asthma,
chronic kidney disease, smoking, obesity, atrial fibrilla-
tion, ischaemic heart diseases.
Statistical analysis
For data analysis, diagnosis of HF was categorized into
confirmed and not confirmed (unconfirmed and mis-
diagnosis). Descriptive data of factors potentially asso-
ciated with the diagnosis are presented. For
categorical variables, frequencies were reported. For
continuous variables, mean and standard deviation
(SD) were calculated. Median and interquartile range
(IQR) were assessed for the variable ‘time since HF
onset,’ which did not follow normal distribution after
using the Kolmogorov–Smirnov test. Chi-square and
Student–Fisher tests for categorical and continuous
variables, respectively, were employed for bivariate
analyses. Variables significantly (p<.05) associated
with the primary outcome in the bivariate analysis
were included as potential covariates in logistic regres-
sion models. Forward and backward step techniques
with the likelihood ratio test were employed.
Multivariate adjusted odds ratios and 95% confidence
intervals were calculated. All analyses were performed
with SPSS Inc. v17.0 software.
Results
Initially, 616 potentially eligible patients with an HF
diagnosis in their primary care electronic medical
records were identified. Twenty-one were excluded
because they either had moved to another PCC or had
died before the validation process (Figure 1). The val-
idation of HF diagnosis was finally carried out in 595
patients. Mean (standard deviation) age was 78 (10)
years and 58% were women. Registered prevalence of
HF was 1.5%. At least one echocardiography was
found in 558 medical records (93.8%). In 13 (2.2%)
patients, the echocardiography had been performed
but information was unavailable.
In 319 (53.6%) patients, the diagnosis of HF was con-
firmed after the revision. Of the 276 (46.4%) patients
with not confirmed HF, 226 were a misdiagnosis, and 50
unconfirmed (Figure 1). Demographic and clinical char-
acteristics of the patients are shown in Table 1.
Among patients with confirmed HF, 32.1% had left
ventricular ejection fraction<50%, 37.8% had abnor-
malities of diastolic relaxation, 30.7% left atrial enlarge-
ment, 21.0% left ventricular hypertrophy, and 5.0%
moderate or severe valve disease.
Table 1. Demographic and clinical characteristics according to the presence of a confirmed diagnosis of heart failure.
Heart failure not confirmed (n¼ 276) n (%)
Total population
(n¼ 595) n (%)
Heart failure
confirmed
(n¼ 319) n (%) Misdiagnosis n¼ 226 Unconfirmed n¼ 50 p
Demographic variables
Age (mean, SD) 78.3 (10.5) 77.3 (11.2) 79.63 (8.1) 78.96(10.7) .02
Sex (women) 346 (58.1) 169 (52.9) 145 (64.1) 32 (65.2) .05
Cardiovascular risk factors
Body mass index (mean, SD) 29.87 (5.2) 29.5 (5.2) 30.2 (5.4) 30.2 (4.5) .52
Hypertension 499 (83.9) 260 (81.5) 201 (8.9) 38 (76) .038
Diabetes mellitus 291 (48.9) 154 (48.3) 121 (53.5) 16 (32) .69
Hypercholesterolaemia 377 (63.4) 208 (65.2) 143 (63.3) 26 (52) .56
Smoking 45 (7.6) 29 (9.1) 14 (6.2) 2 (4) .09
Cardiovascular comorbidities
Ischaemic heart disease 165 (27.7) 121 (37.9) 39 (17.2) 5 (10) <.01
Atrial fibrillation 236 (39.7) 161 (50.4) 61 (26.9) 14 (28) <.01
No cardiovascular comorbidities
Chronic kidney disease 152 (25.5) 93 (29.5) 46 (20.3) 13 (26) .04
Chronic obstructive pulmonary disease 158 (26.5) 102 (31.9) 45 (19.9) 11 (22) .01
Asthma 30 (5.0) 14 (4.4) 15 (6.6) 1 (2) .58
Other variables
Visits by cardiologist 319 (53.6) 227 (71.1) 89 (39.4) 3 (6) <.01
ECG normal 36 (6.1) 18 (5.6) 17 (7.5) 1 (0.2) .65
Loop diuretics 321 (53.9) 207 (64.9) 114 (50.4) 12 (24) <.01
Time since onset (years) [interquartile range] 4 [3–8] 4 [3–8] 4 [3–8] .9
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Multivariate regression models showed that the fac-
tors associated with a higher probability of having
confirmed diagnosis of HF were age (yearly OR: 0.97,
95%CI: 0.95–0.99), cardiologist follow-up (OR: 3.66,
95%CI: 2.46–5.48), history of ischaemic heart disease
(OR: 2.18, 95%CI: 1.36–2.48), atrial fibrillation (OR: 2.01,
95%CI: 1.34–3.03), and prescription of loop diuretics
(OR: 3.24, 95%CI: 2.14–4.89) (Table 2).
Discussion
Main findings
In this study, we found that it was possible to confirm
further HF diagnosis in only half of the patients
labelled as such in the primary care medical records.
Patients with cardiologist follow-up, and those with
a history of ischaemic heart disease, atrial fibrillation,
2 PCC 
39000 INHABITANTS REGISTERED
616 PATIENTS WITH HF LABEL 
IDENTIFIED 
21 PATIENTS EXCLUDED (4 DIED 
17 MOVED PCP)
319 PATIENTS DIAGNOSIS HF 
CONFIRMED 
276 PATIENTS DIAGNOSIS HF NOT 
CONFIRMED 
261 PATIENTS WITH 
SIGN AND SYMPTOMS 
AND 
ECHOCARDIOGRAPHY 
SHOWING 
STRUCTURAL 
ANOMALIES 
2 PATIENTS WITHOUT 
SIGN AND SYMPTOMS 
AND 
ECHOCARDIOGRAPHY 
SHOWING 
STRUCTURAL 
ANOMALIES 
56 PATIENTS ONLY 
INFORMATION ABOUT 
A PRIOR WELL-
DOCUMENTED 
HOSPITALIZATION AS 
A CONSEQUENCE OF 
HF 
197 PATIENTS WITH 
SIGN AND SYMPTOMS 
AND 
ECHOCARDIOGRAPHY 
NOT SHOWING 
STRUCTURAL 
ANOMALIES 
29 PATIENTS NEITHER 
REGISTRATION OF SIGNS 
AND SYMPTOMS NOR 
ECHOCARDIOGRAPHY 
SHOWING STRUCTURAL 
ANOMALIES 
50 PATIENTS WITH 
ECHOCARDIOGRAPHY 
NOT DONE OR 
INFORMATION NOT 
AVAILABLE  
226 PATIENTS MISDIAGNOSIS 50 PATIENTS HF 
UNCONFIRMED
317 PATIENTS SYMPTOMATIC HF  2 PATIENTS 
ASYMPTOMATIC HF 
595 PATIENTS INCLUDED 
Figure 1. Validation of heart failure diagnosis. PCC: primary care centres, HF: heart failure.
Table 2. Univariable and multivariable analysis and confirmed diagnosis of heart failure.
Univariate analysis Multivariate analysisa
OR (95%CI) p OR (95%CI) p
Demographic variables
Age 0.96 (0.94–0.99)b .01 0.97 (0.95–0.99) .04
Sex (women) 1.07 (0.58–1.95) .82 0.74 (0.49–1.13) .16
Cardiovascular risk factors
Body mass index 0.91 (0.92–1.02) .21
Hypertension 1.03 (0.52–2.05) .92
Diabetes mellitus 1.23 (0.74–2.05) .40
Hypercholesterolaemia 0.93 (0.56–1.55) .80
Smoking 0.71 (0.36–1.39) .32
Cardiovascular comorbidities
Ischaemic heart disease 1.76 (1.03–3.18) .04 2.17 (1.36–3.48) .01
Atrial fibrillation 1.68 (1.01–2.78) .04 2.01 (1.34–30.3) .01
No cardiovascular comorbidities
Chronic kidney disease 1.16 (0.67–2.00) .58
Chronic obstructive pulmonary disease 1.37 (0.74–2.54) .32
Asthma 1.39 (0.50–3.90) .53
Other variables
Visits by cardiologist 4.83 (2.92–7.99) <.01 3.66 (2.46–5.47) <.01
ECG normal 0.52 (0.11–2.16 .44
Loop diuretics 3.48 (2.07–5.84) <.01 3.23 (2.14–4.89) <.01
Time since onset 0.99 (0.93–1.05) .77
aMultivariate analysis has been adjusted for age, sex and variables statistically significant at the univariate.
bAge: OR per year.
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and receiving loop diuretics, are more likely to have a
confirmed HF diagnosis.
Strengths and limitations
To confirm diagnostic accuracy, a systematic protocol
agreement was established for both GPs and
cardiologists.
Information was collected retrospectively on diag-
nosis. As a result, it is possible that some signs and
symptoms were not registered in the patient’s medical
records.
Previous research has demonstrated that, in the pri-
mary care setting, the use of NT-proBNP in the assess-
ment of patients with possible HF increases diagnostic
accuracy [24]. Unfortunately, natriuretic peptide deter-
mination is not available in our daily practice.
The main limitation of the study could be that it
was carried out, for reasons of feasibility, in only two
PCCs, which are also involved in protocols with cardi-
ologists and this could affect the external validity of
the study. Another limitation is that, unfortunately, we
do not have data that allow us to assess the variability
of the diagnosis according to the characteristics of the
GPs.
Interpretation of the study: Results in relation to
existing literature
The registered prevalence of HF in our study (1.5%)
was greater than in other previously reported studies
using a similar methodology [25], and a high percent-
age of patients in our sample were found to have had
an echocardiography registered in their medical
records. This could be because for several years the
participating PCCs have taken part in an integrated HF
care programme involving specialized and primary
care sharing management protocols. This kind of
experience has shown to be successful in the diagno-
sis and management of HF patients [26,27].
A recent meta-analysis reported that more than
85% of HF diagnoses could be confirmed through the
data available in the administrative database [28].
However, most studies in this meta-analysis used clin-
ical criteria as the gold standard to confirm the diag-
nosis and were hospital-based. A study carried out in
primary care found that only in 34% of patients
labelled as HF in primary care medical records could
diagnosis be confirmed [29].
The elevated number of patients labelled as HF and
having a normal echocardiogram is noteworthy. It is
possible that their echocardiography had been
performed months or years after the diagnosis was
recorded.
In Europe, it is frequent to find HF diagnosis in gen-
eral practice without confirmatory tests [5,13].
The proportion of patients with no evidence of
signs or symptoms agrees with other studies where it
appears that GPs are less likely to record them than
the results of complementary tests [7,10,28].
Regarding the association of morbidity related to
confirmed diagnosis, it is known that atrial fibrillation
is associated with HF-PEF and that coronary artery dis-
ease is the origin of two-thirds of systolic HF [24].
Previous studies had found a high probability of HF
misdiagnosis when a history of coronary heart disease
or atrial fibrillation was not present [19,20].
The association of HF diagnosis with the prescrip-
tion of diuretics has also been described [10,21]. It is
probable that patients with symptoms due to volume
load are often treated with loop diuretics. In fact, the
latest European Society of Cardiology guidelines
included the use of this medication as a suspected HF
factor [29]. Nevertheless, at least one consultation with
the cardiologist is recommended to confirm the initial
diagnosis [27,30].
We believe that our findings could be extrapolated
to other countries with health systems and popula-
tions similar to ours. The variables which we have
found related to confirmed HF are usually collected in
primary care and should not differ amongst other
European countries [31,32].
Implications for clinical practice
The diagnosis of HF in the medical records of the
patient is an important label that conditions treat-
ments, tests, and interventions. The accuracy of diag-
nosis, however, remains a challenge: HF signs and
symptoms are not specific, and in many cases difficult
to identify. Diagnosis requires demonstrating cardiac
dysfunction.
The data from our work support the need to per-
form periodic self-audit in patients registered with HF.
It should be prioritized in those patients who do not
meet criteria to confirm diagnosis, performing the
necessary examinations or additional tests. Once
patients are re-classified, databases should be
adjusted, removing the registry of HF in those patients
in whom diagnosis has been ruled out after a correct
revision. In this way, unnecessary interventions and
treatments can be avoided. The results of our study
also support, especially in case of doubt, the need for
the collaboration of the cardiologist in confirming
diagnosis.
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Conclusion
Only in half of the patients labelled as heart failure in
primary care medical records could this diagnosis be
further confirmed.
Variables regularly registered in clinical practice
records could help general practitioners identify those
patients requiring a revision of their heart failure
diagnosis.
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